In recent years, the co-amorphous drug formulations have gradually become a new type of drug delivery system with great potential. Co-amorphous drug formulations can improve the stability of amorphous drugs and improve the solubility and dissolution of poorly water-soluble drugs, thereby potentially improving their bioavailability and therapeutic effects. This paper reviews co-amorphous drugs from the perspectives of preparation methods, physicochemical properties, physical stability, and in vitro performance, and clarifieds the in vivo advantages of co-amorphous drugs through a review of the pharmacokinetics of several classic drugs. In particular, the advantages of co-amorphous drugs in theory, preparation technology, and physicochemical properties are discussed to provide a reference for the further development of high-quality co-amorphous drug formulations.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |